A sound wave that could expose hidden pancreatic cancer?
NCT ID NCT06157671
First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This trial is testing a new, noninvasive method called LINFU® that uses low-intensity ultrasound to stimulate the pancreas, helping to collect pancreatic juice for analysis. The goal is to see if this approach can detect early, asymptomatic pancreatic cancer and precancerous lesions better than current screening methods. The study enrolls 1,000 people at high risk for pancreatic cancer due to factors like smoking, diabetes, or family history. If it works, this could lead to a safer, more effective way to catch this deadly disease early.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- LINFU® (Low Intensity Non-Focused Ultrasound excitation of the pancreas) followed by analysis of pancreatic juice
- What this could lead to
- If successful, this could lead to a noninvasive screening tool that catches pancreatic cancer early, when it's more treatable, potentially saving lives.
- What could go wrong
- This is an early-stage registry study, so the method may not prove more effective than current screening tests. It also requires analysis of pancreatic juice, which may be complex and not widely available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Manhattan Endoscopy Center
New York, New York, 10017, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pancreatic Cancer's inflammatory footprint be stopped?
- Blood and gut clues may flag pancreatic cancer risk early
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can a pill outsmart Tumors' defenses?
- Can a pill rouse the immune system against pancreatic cancer?
- Can a new immunotherapy combo shrink Hard-to-Treat tumors?